Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Vanda Pharmaceuticals Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 144 | 148 | +4 |
| Shares | 48.2M | 43.5M | −4.62M (−9.6%) |
| Value | $198.0M | $246.0M | +$48.0M (+24.2%) |
New holders (38)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (34)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q1 2024 and filed for Q2 2024 without it.